Antierythropoietin antibody-induced pure red cell aplasia: Posttransplant evolution

Pediatric Nephrology

Volumn 19, Issue 9, 2004, Pages 1059-1061

  Alonso Melgar, Agel ^a   Melgosa Hijosa, Marta ^a   Pardo de la Vega, Rafael ^a   García Meseguer, Carmen ^a   Navarro Torres, Mercedes ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Antierythropoietin antibodies; Cyclosporin A; Pure red cell aplasia; Transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; ERYTHROPOIETIN; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTRALIZING ANTIBODY; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; DISEASE EXACERBATION; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNIZATION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; OBSTRUCTIVE UROPATHY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RISK REDUCTION;

ADOLESCENT; ANTIBODIES; ERYTHROPOIETIN, RECOMBINANT; HUMANS; KIDNEY TRANSPLANTATION; MALE; RED-CELL APLASIA, PURE;

EID: 4544284707     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1489-x     Document Type: Article

References (12)

1. Bergrem H, Danielson BG, Eckardt K-U, Kurtz A, Stridsberg M (1993) A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In: Erythropoietin: molecular physiology and clinical application. Dekker, New York, pp 266-275
2. Peces R, Torre M de la, Alcázar R, Urra JM (1996) Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 335:523-524
3. Prabhakar SS, Muhlfelder T (1997) Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 47:331-335
4. Eckardt A-U, Casadevall N (2003) Pure red-cell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 18:865-869
5. Bunn HF (2002) Drug-induced autommume red-cell aplasia. N Engl J Med 346:522-523
6. Krantz SB (1974) Pure red-cell aplasia. N Engl J Med 291:345-350
7. Kiely PDW, McGuckin CP, Collins DA, Bevan DH, Marsh JC (1995) Erythrocyte aplasia and systemic lupus erythematosus. Lupus 14:407-411
8. Agencia Española del Medicamento (2002) Comunicación sobre riesgos de medicamentos para profesionales sanitarios: Epoetina Alfa
9. Weber G, Gross J, Kromminga A, Loew HH, Eckardt K-U (2002) Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. J Am Soc Nephrol 13:2381-2383
10. Cases A, Esforzado N, Mas M, Ricart MJ, Cruzado JM (2003) Aplasia pura de la serie roja asociada a anticuerpos neutralizantes frente a eritropoyetina inducida por epoetina alfa: una nueva forma de eritroblastopenia adquirida en pacientes urémicos. Nefrologia 23:266-270
11. Chng W, Tan L, Liu T (2003) Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy. Am J Kidney Dis 41:692-695
12. Duarte-Salazar C, Cazarin-Barrientos J, Goycoechea-Robles MV, Collazo-Jaloma J, Burgos-Vargas R (2000) Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology 39: 1155-1157